收藏切换
Mechanism of tanshinone IIA to prevent spontaneous breast cancer in mice
收藏切换
PDF
Yuan WANG1, Xiao-feng LI2, Ye SUN1, Jun-de XU1, Yi-chuang WU1, Peng WAN1, Rui DENG1, Xiu-qin ZHENG1, Xiao-man LI1, Yang ZHAO2, Yin LU1, 3, *, Yuan-yuan WU1, *
Acta Pharmaceutica Sinica | 2021, 56(12) : 3277 - 3284
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(12): 3277-3284
Special Reports Ⅰ: Anti-tumor Preparations of Traditional Chinese Medicine
Mechanism of tanshinone IIA to prevent spontaneous breast cancer in mice
Full
Yuan WANG1, Xiao-feng LI2, Ye SUN1, Jun-de XU1, Yi-chuang WU1, Peng WAN1, Rui DENG1, Xiu-qin ZHENG1, Xiao-man LI1, Yang ZHAO2, Yin LU1, 3, *, Yuan-yuan WU1, *
Affiliations
  • 1. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
  • 2. School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
  • 3. Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China
Published: 2021-12-12 doi: 10.16438/j.0513-4870.2021-1468
Outline
收藏切换

To explore the effect of tanshinone IIA (TanIIA) on the occurrence and development of breast cancer, we employed the mouse mammary tumor virus-polyomavirus middle T antigen (MMTV-PyMT) transgenic mice as a spontaneous breast cancer mouse model. Animal welfare and experimental procedures were in accordance with the regulations of the Animal Ethics Committee of Nanjing University of Chinese Medicine. The animals were divided into control group, low-dose TanIIA treatment group (30 mg·kg-1·day-1), and high-dose TanIIA treatment group (60 mg·kg-1·day-1). The treatment was administered orally and daily for 5 weeks. The mice were sacrificed after final treatment. Mammary gland and lung were collected for histopathology studies. We evaluated the chemoprophylaxis effect of TanIIA on breast cancer in mice according to the pathological characteristics of breast cancer at different stages of development. Immunofluorescence staining were employed for blood vessel analysis. The expression levels of E-cadherin, proliferating nuclear antigen (PCNA), and oncogene c-Myc were detected by immunohistochemistry. Flow cytometry was used to analyze cell cycle and Cytoscape was used to construct drug-disease protein-protein interaction (PPI) network. Our results showed that TanIIA inhibits breast tumor progression by delaying malignancy from adenoma to early carcinoma, and inhibits blood vessel formation during tumor development. TanIIA (60 mg·kg-1·day-1) inhibits the expression levels of PCNA and c-Myc, upregulates the expression of E-cadherin. In addition, cell cycle experiments showed that the cell cycle of PyMT primary mammary cells in the high-dose TanIIA group was arrested in the G0/G1 phase. Our study demonstrated that TanIIA can significantly inhibit breast tumor progression in MMTV-PyMT mouse model, which may be related to the inhibition of angiogenic switch and cell cycle arrest.

tanshinone IIA  /  Salvia miltiorrhiza  /  breast neoplasm  /  chemoprevention  /  carcinogenesis
Yuan WANG, Xiao-feng LI, Ye SUN, Jun-de XU, Yi-chuang WU, Peng WAN, Rui DENG, Xiu-qin ZHENG, Xiao-man LI, Yang ZHAO, Yin LU, Yuan-yuan WU. Mechanism of tanshinone IIA to prevent spontaneous breast cancer in mice[J]. Acta Pharmaceutica Sinica, 2021 , 56 (12) : 3277 -3284 . DOI: 10.16438/j.0513-4870.2021-1468
Year 2021 volume 56 Issue 12
PDF
175
73
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-1468
  • Receive Date:2021-10-12
  • Online Date:2025-12-18
  • Published:2021-12-12
Article Data
Affiliations
History
  • Received:2021-10-12
  • Revised:2021-11-04
Funding
Affiliations
    1. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
    2. School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
    3. Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-1468
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT